- Entry
- $4.15
- Now
- $6.38 +53.7%
- Target
- —
- Score
- —
$CAPR Pending approval on August 22nd for DERAMIOCEL, for DMD patients. Must see now! The Adcomm decision did not rule in favor for Capricor Therapeutics $CAPR, on January 29th and there is much debate as to why when DERAMIOCEL works for MANY boys with the rare but debilitating disease of DMD. I would not be surprised one bit to see accelerated approval immediately once all the shenanigans of the p values are hashed out. I expect full resolution! God bless …
— ORIGINAL POST ·
Sign the Petition
· r/pennystocks
· Aug 2, 2026